{"pmid":32335609,"title":"Clinical Profile of Cases of COVID-19 in Far Western Province of Nepal.","text":["Clinical Profile of Cases of COVID-19 in Far Western Province of Nepal.","The novel coronavirus (COVID-19) cause various symptoms such as pneumonia, fever, breathing difficult and lung infection. Till now, total 9 cases are reported in Nepal and 4 cases from this province. This case series is to describe the initial clinical features of COVID-19 among the patients admitted in isolation ward of Seti Provincial Hospital. Oropharyngeal swab was taken from all four patients and sample was transfer to national reference laboratory. Three patients were coming from infected country and one is local transmission. Age of patients was range from 20 to 40 years of age with male preponderance. The patient coming from United Arab Emirate was presented with mild symptoms and others were asymptomatic. More tests, contact tracing and keeping them in quarantine are the necessitated action need to be taken by government of Nepal. Keywords: COVID-19; local transmission; oropharyngeal swab.","J Nepal Health Res Counc","Joshi, Jagadish","Mishra, Pradip","Kamar, Sher Bahadur","Sharma, Nirajan Datta","Parajuli, Janaki","Sharma, Seema","Pandey, Hem Raj","32335609"],"abstract":["The novel coronavirus (COVID-19) cause various symptoms such as pneumonia, fever, breathing difficult and lung infection. Till now, total 9 cases are reported in Nepal and 4 cases from this province. This case series is to describe the initial clinical features of COVID-19 among the patients admitted in isolation ward of Seti Provincial Hospital. Oropharyngeal swab was taken from all four patients and sample was transfer to national reference laboratory. Three patients were coming from infected country and one is local transmission. Age of patients was range from 20 to 40 years of age with male preponderance. The patient coming from United Arab Emirate was presented with mild symptoms and others were asymptomatic. More tests, contact tracing and keeping them in quarantine are the necessitated action need to be taken by government of Nepal. Keywords: COVID-19; local transmission; oropharyngeal swab."],"journal":"J Nepal Health Res Counc","authors":["Joshi, Jagadish","Mishra, Pradip","Kamar, Sher Bahadur","Sharma, Nirajan Datta","Parajuli, Janaki","Sharma, Seema","Pandey, Hem Raj"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32335609","week":"202018|Apr 27 - May 03","doi":"10.33314/jnhrc.v18i1.2602","source":"PubMed","topics":["Diagnosis","Transmission","Prevention"],"weight":1,"locations":["Nepal","Nepal","Far Western","Nepal"],"countries":["Nepal"],"countries_codes":["NPL|Nepal"],"_version_":1665172301942882304,"score":8.518259,"similar":[{"pmid":32335608,"title":"Nepal's Response to Contain COVID-19 Infection.","text":["Nepal's Response to Contain COVID-19 Infection.","Nepal is a landlocked country bordering two most populous countries, India and China. Nepal shares open border with India from three sides, east, south and west. And, in north with China, where the novel coronavirus infection (CVOVID-19) began in late December 2019. The first confirmed imported case in Nepal was reported in 2nd week of January 2020. The initial response of Nepal to COVID-19 were comparably slow but country geared efforts after it was declared a 'global pandemic' by WHO on 11 March, 2020. Government of Nepal's steps from 18 March, 2020 led to partial lock down and countrywide lockdown imposed on 24 March, 2020. Government devised comprehensive plan on 27 March, 2020 for quarantine for peoples who arrived in Nepal from COVID-19 affected countries. This article covers summary of global status, South Asian Association of Regional Cooperation (SAARC) status, and Nepal's response to contain COVID-19 infection discussed under three headings: Steps taken before and after WHO declared COVID-19 a global pandemic and lab services regarding detection of COVID-19. Nepal has documented five confirmed cases of COVID-19 till the end of March 2020, first in second week of 15 January, 2020 and 2nd case 8-weeks thereafter and 3rd case two days later, 4th on 27 March and 5th on 28 March. Four more cases detected during first week of April. Non-Pharmacological interventions like social distancing and excellent personal habits are widely practiced. Country has to enhance testing and strengthen tracing, isolation and quarantine mechanism and care of COVID-19 patients as Nepal is in risk zone because of comparably weak health system and porous borders with India. The time will tell regarding further outbreak and how it will be tackled. Keywords: COVID-19; lockdown; Nepal; pandemic; response.","J Nepal Health Res Counc","Piryani, Rano Mal","Piryani, Suneel","Shah, Jay Narayan","32335608"],"abstract":["Nepal is a landlocked country bordering two most populous countries, India and China. Nepal shares open border with India from three sides, east, south and west. And, in north with China, where the novel coronavirus infection (CVOVID-19) began in late December 2019. The first confirmed imported case in Nepal was reported in 2nd week of January 2020. The initial response of Nepal to COVID-19 were comparably slow but country geared efforts after it was declared a 'global pandemic' by WHO on 11 March, 2020. Government of Nepal's steps from 18 March, 2020 led to partial lock down and countrywide lockdown imposed on 24 March, 2020. Government devised comprehensive plan on 27 March, 2020 for quarantine for peoples who arrived in Nepal from COVID-19 affected countries. This article covers summary of global status, South Asian Association of Regional Cooperation (SAARC) status, and Nepal's response to contain COVID-19 infection discussed under three headings: Steps taken before and after WHO declared COVID-19 a global pandemic and lab services regarding detection of COVID-19. Nepal has documented five confirmed cases of COVID-19 till the end of March 2020, first in second week of 15 January, 2020 and 2nd case 8-weeks thereafter and 3rd case two days later, 4th on 27 March and 5th on 28 March. Four more cases detected during first week of April. Non-Pharmacological interventions like social distancing and excellent personal habits are widely practiced. Country has to enhance testing and strengthen tracing, isolation and quarantine mechanism and care of COVID-19 patients as Nepal is in risk zone because of comparably weak health system and porous borders with India. The time will tell regarding further outbreak and how it will be tackled. Keywords: COVID-19; lockdown; Nepal; pandemic; response."],"journal":"J Nepal Health Res Counc","authors":["Piryani, Rano Mal","Piryani, Suneel","Shah, Jay Narayan"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32335608","week":"202018|Apr 27 - May 03","doi":"10.33314/jnhrc.v18i1.2608","source":"PubMed","topics":["Prevention"],"weight":1,"locations":["India","China","Nepal","India","China","Nepal","Nepal","Nepal","Nepal","Nepal","India","Nepal","Nepal"],"countries":["Nepal","China","India"],"countries_codes":["NPL|Nepal","CHN|China","IND|India"],"_version_":1665172301943930880,"score":357.20377},{"pmid":32335607,"title":"Understanding COVID-19 in Nepal.","text":["Understanding COVID-19 in Nepal.","The novel coronavirus COVID-19 (SARS-CoV-2) was first reported in 31 December 2019 in Wuhan City, China. The first case of COVID-19 was officially announced on 24 January, 2020, in Nepal. Nine COVID-19 cases have been reported in Nepal. We aim to describe our experiences of COVID-19 patients in Nepal. Keywords: COVID-19; experience; Nepal.","J Nepal Health Res Counc","Pun, Sher Bahadur","Mandal, Shrawan","Bhandari, Lilanath","Jha, Santoshananda","Rajbhandari, Sagar","Mishra, Abdhesh Kumar","Sharma Chalise, Bimal","Shah, Rajesh","32335607"],"abstract":["The novel coronavirus COVID-19 (SARS-CoV-2) was first reported in 31 December 2019 in Wuhan City, China. The first case of COVID-19 was officially announced on 24 January, 2020, in Nepal. Nine COVID-19 cases have been reported in Nepal. We aim to describe our experiences of COVID-19 patients in Nepal. Keywords: COVID-19; experience; Nepal."],"journal":"J Nepal Health Res Counc","authors":["Pun, Sher Bahadur","Mandal, Shrawan","Bhandari, Lilanath","Jha, Santoshananda","Rajbhandari, Sagar","Mishra, Abdhesh Kumar","Sharma Chalise, Bimal","Shah, Rajesh"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32335607","week":"202018|Apr 27 - May 03","doi":"10.33314/jnhrc.v18i1.2629","source":"PubMed","weight":0,"locations":["Wuhan","China","Nepal","Nepal","Nepal","Nepal","Nepal"],"countries":["Nepal","China"],"countries_codes":["NPL|Nepal","CHN|China"],"_version_":1665172301875773440,"score":277.7284},{"pmid":32165386,"pmcid":"PMC7067954","title":"Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal.","text":["Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal.","A complete genome sequence was obtained for a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain isolated from an oropharyngeal swab specimen of a Nepalese patient with coronavirus disease 2019 (COVID-19), who had returned to Nepal after traveling to Wuhan, China.","Microbiol Resour Announc","Sah, Ranjit","Rodriguez-Morales, Alfonso J","Jha, Runa","Chu, Daniel K W","Gu, Haogao","Peiris, Malik","Bastola, Anup","Lal, Bibek Kumar","Ojha, Hemant Chanda","Rabaan, Ali A","Zambrano, Lysien I","Costello, Anthony","Morita, Kouichi","Pandey, Basu Dev","Poon, Leo L M","32165386"],"abstract":["A complete genome sequence was obtained for a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain isolated from an oropharyngeal swab specimen of a Nepalese patient with coronavirus disease 2019 (COVID-19), who had returned to Nepal after traveling to Wuhan, China."],"journal":"Microbiol Resour Announc","authors":["Sah, Ranjit","Rodriguez-Morales, Alfonso J","Jha, Runa","Chu, Daniel K W","Gu, Haogao","Peiris, Malik","Bastola, Anup","Lal, Bibek Kumar","Ojha, Hemant Chanda","Rabaan, Ali A","Zambrano, Lysien I","Costello, Anthony","Morita, Kouichi","Pandey, Basu Dev","Poon, Leo L M"],"date":"2020-03-14T11:00:00Z","year":2020,"_id":"32165386","week":"202011|Mar 09 - Mar 15","doi":"10.1128/MRA.00169-20","source":"PubMed","topics":["Mechanism"],"weight":1,"locations":["swab","Nepalese","Nepal","Wuhan","China","Nepal"],"countries":["China","Nepal"],"countries_codes":["CHN|China","NPL|Nepal"],"_version_":1664640874760372226,"score":269.65057},{"pmid":32335628,"title":"Air Medical Evacuation of Nepalese Citizen During Epidemic of COVID-19 from Wuhan to Nepal.","text":["Air Medical Evacuation of Nepalese Citizen During Epidemic of COVID-19 from Wuhan to Nepal.","In December 2019, the world was disrupted by the news of a new strain of virus known as Novel Corona virus, taking lives of many in China. Wuhan, the capital of Central China's Hubei province is said to be the place where the outbreak started. The city went on a lockdown as the disease spread rapidly. After the lockdown, most countries like India and Bangladesh airlifted their citizens who were studying in Wuhan. Similarly, Nepal also has many youth studying medicine in Wuhan. Pleas for help from the students reached the government. This was a first encounter of such experience for Nepal government. With the help of Health Emergency Organizing committee, Epidemiology and Disease Control Division, Nepal Army Hospital, Nepal Police Hospital, Waste Management team, Nepal Ambulance service, Tribhuwan Airport and Royal Airlines the government of Nepal planned, organized and successfully brought back all the 175 students on 15 the February, 2019 from Wuhan, China. The aim of the present article is to share the experience, the challenges faced and recommendations for future similar cases. Keywords: evacuation; Nepal; Novel Corona virus; Wuhan.","JNMA J Nepal Med Assoc","Rajbhandari, Bibek","Phuyal, Naveen","Shrestha, Bikal","Thapa, Moon","32335628"],"abstract":["In December 2019, the world was disrupted by the news of a new strain of virus known as Novel Corona virus, taking lives of many in China. Wuhan, the capital of Central China's Hubei province is said to be the place where the outbreak started. The city went on a lockdown as the disease spread rapidly. After the lockdown, most countries like India and Bangladesh airlifted their citizens who were studying in Wuhan. Similarly, Nepal also has many youth studying medicine in Wuhan. Pleas for help from the students reached the government. This was a first encounter of such experience for Nepal government. With the help of Health Emergency Organizing committee, Epidemiology and Disease Control Division, Nepal Army Hospital, Nepal Police Hospital, Waste Management team, Nepal Ambulance service, Tribhuwan Airport and Royal Airlines the government of Nepal planned, organized and successfully brought back all the 175 students on 15 the February, 2019 from Wuhan, China. The aim of the present article is to share the experience, the challenges faced and recommendations for future similar cases. Keywords: evacuation; Nepal; Novel Corona virus; Wuhan."],"journal":"JNMA J Nepal Med Assoc","authors":["Rajbhandari, Bibek","Phuyal, Naveen","Shrestha, Bikal","Thapa, Moon"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32335628","week":"202018|Apr 27 - May 03","source":"PubMed","topics":["Prevention"],"weight":1,"locations":["China","Wuhan","Hubei","India","Bangladesh","Wuhan","Nepal","Wuhan","Nepal","Wuhan","China","Nepal","Wuhan","Wuhan","Nepal"],"countries":["Nepal","Bangladesh","China","India"],"countries_codes":["NPL|Nepal","BGD|Bangladesh","CHN|China","IND|India"],"_version_":1665172301980631040,"score":266.2782},{"pmid":32146694,"title":"Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China.","text":["Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China.","Previous studies have showed clinical characteristics of patients with the 2019 novel coronavirus disease (COVID-19) and the evidence of person-to-person transmission. Limited data are available for asymptomatic infections. This study aims to present the clinical characteristics of 24 cases with asymptomatic infection screened from close contacts and to show the transmission potential of asymptomatic COVID-19 virus carriers. Epidemiological investigations were conducted among all close contacts of COVID-19 patients (or suspected patients) in Nanjing, Jiangsu Province, China, from Jan 28 to Feb 9, 2020, both in clinic and in community. Asymptomatic carriers were laboratory-confirmed positive for the COVID-19 virus by testing the nucleic acid of the pharyngeal swab samples. Their clinical records, laboratory assessments, and chest CT scans were reviewed. As a result, none of the 24 asymptomatic cases presented any obvious symptoms while nucleic acid screening. Five cases (20.8%) developed symptoms (fever, cough, fatigue, etc.) during hospitalization. Twelve (50.0%) cases showed typical CT images of ground-glass chest and 5 (20.8%) presented stripe shadowing in the lungs. The remaining 7 (29.2%) cases showed normal CT image and had no symptoms during hospitalization. These 7 cases were younger (median age: 14.0 years; P=0.012) than the rest. None of the 24 cases developed severe COVID-19 pneumonia or died. The median communicable period, defined as the interval from the first day of positive nucleic acid tests to the first day of continuous negative tests, was 9.5 days (up to 21 days among the 24 asymptomatic cases). Through epidemiological investigation, we observed a typical asymptomatic transmission to the cohabiting family members, which even caused severe COVID-19 pneumonia. Overall, the asymptomatic carriers identified from close contacts were prone to be mildly ill during hospitalization. However, the communicable period could be up to three weeks and the communicated patients could develop severe illness. These results highlighted the importance of close contact tracing and longitudinally surveillance via virus nucleic acid tests. Further isolation recommendation and continuous nucleic acid tests may also be recommended to the patients discharged.","Sci China Life Sci","Hu, Zhiliang","Song, Ci","Xu, Chuanjun","Jin, Guangfu","Chen, Yaling","Xu, Xin","Ma, Hongxia","Chen, Wei","Lin, Yuan","Zheng, Yishan","Wang, Jianming","Hu, Zhibin","Yi, Yongxiang","Shen, Hongbing","32146694"],"abstract":["Previous studies have showed clinical characteristics of patients with the 2019 novel coronavirus disease (COVID-19) and the evidence of person-to-person transmission. Limited data are available for asymptomatic infections. This study aims to present the clinical characteristics of 24 cases with asymptomatic infection screened from close contacts and to show the transmission potential of asymptomatic COVID-19 virus carriers. Epidemiological investigations were conducted among all close contacts of COVID-19 patients (or suspected patients) in Nanjing, Jiangsu Province, China, from Jan 28 to Feb 9, 2020, both in clinic and in community. Asymptomatic carriers were laboratory-confirmed positive for the COVID-19 virus by testing the nucleic acid of the pharyngeal swab samples. Their clinical records, laboratory assessments, and chest CT scans were reviewed. As a result, none of the 24 asymptomatic cases presented any obvious symptoms while nucleic acid screening. Five cases (20.8%) developed symptoms (fever, cough, fatigue, etc.) during hospitalization. Twelve (50.0%) cases showed typical CT images of ground-glass chest and 5 (20.8%) presented stripe shadowing in the lungs. The remaining 7 (29.2%) cases showed normal CT image and had no symptoms during hospitalization. These 7 cases were younger (median age: 14.0 years; P=0.012) than the rest. None of the 24 cases developed severe COVID-19 pneumonia or died. The median communicable period, defined as the interval from the first day of positive nucleic acid tests to the first day of continuous negative tests, was 9.5 days (up to 21 days among the 24 asymptomatic cases). Through epidemiological investigation, we observed a typical asymptomatic transmission to the cohabiting family members, which even caused severe COVID-19 pneumonia. Overall, the asymptomatic carriers identified from close contacts were prone to be mildly ill during hospitalization. However, the communicable period could be up to three weeks and the communicated patients could develop severe illness. These results highlighted the importance of close contact tracing and longitudinally surveillance via virus nucleic acid tests. Further isolation recommendation and continuous nucleic acid tests may also be recommended to the patients discharged."],"journal":"Sci China Life Sci","authors":["Hu, Zhiliang","Song, Ci","Xu, Chuanjun","Jin, Guangfu","Chen, Yaling","Xu, Xin","Ma, Hongxia","Chen, Wei","Lin, Yuan","Zheng, Yishan","Wang, Jianming","Hu, Zhibin","Yi, Yongxiang","Shen, Hongbing"],"date":"2020-03-09T11:00:00Z","year":2020,"_id":"32146694","week":"202011|Mar 09 - Mar 15","doi":"10.1007/s11427-020-1661-4","keywords":["covid-19","china","asymptomatic infections","close contact"],"source":"PubMed","topics":["Mechanism","Diagnosis","Transmission"],"weight":1,"locations":["Nanjing","Jiangsu","China","Nanjing","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640874887249920,"score":247.18001}]}